Diets rich in omega-3 fatty acids derived from fish oils lower the plasma concentrations of low density lipoproteins (LDL) and very low density lipoproteins in humans. The present study was designed to examine the mechanism(s) by which diets enriched in omega-3 fatty acids reduce plasma LDL cholesterol levels in normal subjects. Seven healthy volunteers with normal plasma lipid levels consumed two metabolically controlled diets for a period of 4 weeks each. The control diet contained predominantly saturated and monounsaturated fatty acids, whereas the fish-oil diet contained 24 gm of omega-3 fatty acids per day. The total fat and cholesterol content of the two diets were similar for each subject. Total and LDL cholesterol levels decreased from 162 ± 26 mg/dl and 103 ± 27 mg/dl on the control diet to 124 ± 26 mg/dl and 82 ± 27 mg/dl on the omega-3-rich diet. Triglyceride levels fell from 91 ± 34 mg/dl to 52 ± 19 mg/dl. Kinetic studies of 125 I-LDL metabolism disclosed a significantly lower rate of synthesis of LDL apoprotein B on the omega-3-rich diet (9.5 ± 1.3 mg/kg/ day) as compared to the control diet (13.6 ± 3.7 mg/kg/day; p < 0.05). In contrast, the fractional catabolic rate was similar on both diets. We conclude that dietary omega-3 fatty acids lower plasma LDL levels in normal human subjects by reducing the rate of synthesis of apoprotein B. (Arteriosclerosis 4:270-275, May/June 1984)
R educed levels of plasma cholesterol and triglyceride have been reported in populations consuming large amounts of seal, whale, and fish oil.
1 " 3 Dyerberg and Bang 2 ' 3 have postulated that omega-3 fatty acids which are present in high concentrations in these diets are responsible for the low plasma lipid levels. The additional findings of prolonged bleeding times and a low incidence of coronary heart disease in this Eskimo population has also led to the sugges-tion that dietary omega-3 fatty acids may be antiatherogenic. 1 " 3 Kromann and Green 4 conducted an epidemiological study of chronic diseases in Northwest Greenland Eskimos during the period, 1950-1974. They found that only three certain and two unproven cases of acute myocardial infarction had been noted in the population base of 1800 people. From previous studies in Denmark, about 40 acute myocardial infarctions would have been expected.
Recent metabolic studies have indicated that when fish oils rich in omega-3 fatty acids are added to the diets of either normal volunteers or hyperlipidemic patients, the plasma concentrations of both cholesterol and triglyceride are reduced. 15 " 7 We have previously shown 6 that dietary fish oils lower plasma concentrations of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) cholesterol levels even more effectively than equal amounts of polyunsaturated vegetable oils. The purpose of the experiments reported in this paper was to examine the mechanism(s) by which dietary omega-3 fatty acids reduce plasma concentrations of LDL in normal human subjects. 
Methods

Subjects
Seven healthy subjects without hyperlipidemia participated in this study (Table 1) . Their mean age was 33 years, and all were within 20% of their ideal body weights. Informed consent was obtained from each subject and the study protocol was approved by the Human Research Committee of the Oregon Health Sciences University. The subjects were fed eucaloric diets which contained 30% or 40% of calories as fat, 15% as protein, and 45% or 55% as carbohydrate. The proportions of fat and carbohydrate were identical in each individual subject on both the control and fish-oil-enriched diets. Dietary composition and cholesterol intakes (140 mg/1000 KCal) were held constant for each subject on both diets. The dietary fats used were either a blend of peanut oil or cocoa butter for the control diet or salmon oil or Maxepa (Marfleet Refining Company, Hull, England). The salmon oil contained 20% of total fatty acids as omega-3 (C20 and C22) fatty acids, whereas Maxepa had about 31%.
The fatty acid composition of the diets is shown in Table 2 . The fish-oil diet provided 24 ± 8 g/day of omega-3 fatty acids, whereas the control diet contained none. To provide this amount of omega-3 fatty acids, we fed about 120 g of salmon oil or about 92 g of Maxepa daily. The cholesterol naturally present in the fish oil was balanced in the control period by the addition of egg yolk. All diets were prepared by dietitians in the metabolic kitchen of the Clinical Research Center, and most meals were eaten at the Center by the study subjects. Other meals were provided for home consumption. Compliance with the dietary regimens was monitored by noting the stability of body weights, by daily contact with the volunteers, and, during the fish-oil period, by measuring the presence of omega-3 fatty acids in the plasma lipids. Supplemental vitamins were provided to meet the recommended dietary allowances. 8 Each subject consumed the control and experimental diet for a period of 4 weeks each. The periods were separated by at least 1 month on the subjects' home diets, thereby allowing for an adequate washout period between each study. On the seventh day of each study period, 15 cc of blood was drawn for isolation of LDL and subsequent labeling with 125 I. The LDL fraction (density = 1.019 to 1.060 g/cc) was iodinated with iodine monochloride by a modification of the method of MacFarlane 9 as suggested by Langer et al. 10 The plasma and its fractions were handled with sterile precautions, passed through a 0.45 /urn Millipore filter, and then tested for bacterial contamination before use. Each subject was started on oral potassium iodide (100 mg/day) 3 days before the study and was maintained on that dosage throughout the subsequent 14-day period of LDL turnover. Labeled LDL was injected after an overnight fast, and blood samples were drawn at frequent intervals during the first 24 hours and daily thereafter for a period of 14 days. Previous studies have shown that little or no 125 I-LDL radioactivity is transferred to other lipoprotein fractions, and analyses were therefore based on total radioactivity per milliliter of plasma. The decay curve thus obtained was fitted by a In the fish-oil periods, Subjects 2 and 6 consumed 30% of total fatty acids as Maxepa; Subjects 3, 5, and 7 consumed 40% of fatty acids from salmon oil; and Subjects 1 and 4 received 30% of calories from salmon oil.
"Calculated from the fatty acid composition.
computer program to a two-pool model, and the fractional catabolic rate (FCR) was determined. 11 ' 12 The product of the LDL apoprotein B pool size multiplied by the FCR is equal to the LDL apoprotein B absolute catabolic rate, which, in the steady state, is equal to the synthetic rate.
Blood samples were obtained under fasting conditions and the plasma was analyzed for cholesterol and triglyceride with the Autoanalyzer. 13 The cholesterol content of the three major lipoprotein fractions (VLDL, LDL, HDL) was determined according to procedures outlined in the Lipid Research Clinics Manual of Operations. 13 LDL protein was measured by the method of Lowry 14 using bovine serum albumin as a standard. These results were not corrected for possible differences in chromogenicity between apoprotein B and the bovine albumin standard. The fatty acid composition of plasma lipids and dietary fats were determined on a 30 meter SP2330 capillary column with a Perkin Elmer Sigma 3B gas chromatograph. Lipid extraction, separation, and preparation of methyl esters were done by standard methods as previously described. 15 Major lipid classes were separated by thin-layer chromatography on silica gel G using the solvent system hexane/diethylether/chloroform/acetic acid 80:10:10:1 by volume. Statistical analyses were performed by paired t tests (twotailed).
Results
Steady-state concentrations of plasma cholesterol and triglyceride on the control and fish-oil-enriched diets were obtained in 10 to 14 days and both were significantly lower on the omega-3 fatty acid-enriched diet (Table 3 ). The total and LDL cholesterol concentrations fell 23% and 20%, respectively, on the fish-oil-enriched diet; these changes were paralleled by a 43% decrease in the concentrations of plasma triglycerides. The cholesterol/protein ratio of LDL was similar on both diets (control 1.41 ± 0.14, omega-3 diet 1.37 ± 0.09, mean ± SD) and indicates that the decreased concentrations of LDL cholesterol were attributable to a decrease in the number of LDL particles present in the plasma of subjects on the fish-oil-enriched diet. Indeed, the mean plasma pool of LDL apoprotein B decreased from 1154 ± 310 mg on the control diet to 906 ± 300 mg (mean ± SD) on the fish-oil-supplemented diet (p < 0.005), a decrease of 21.5% (see Table 5 ).
The fatty acid profile of plasma lipids reflected the increased consumption of omega-3 fatty acids on the fish-oil-enriched diet as compared to the control diets (Table 4 ). In the phospholipid fraction the percentage of omega-3 fatty acids rose from 4.7% to 34% largely at the expense of linoleic acid which decreased from 30% to 6% of the total fatty acids. A similar pattern was seen in the plasma cholesterol esters. The increase in omega-3 fatty acids, which was due almost entirely to an increase in eicosapentaenoic acid from 1% to 27%, was accompanied by increases in palmitic and oleic acid but a marked decrease in linoleic acid (from 63% to 20%). Thus, the fish-oil-enriched diet led to a significant incorporation of omega-3 fatty acids into the lipid components of the plasma lipoproteins and was accompanied by a corresponding fall in the proportions of linoleic acid.
Kinetic studies of the turnover of 125 I-LDL were conducted under steady-state conditions (Days 14-28) on each of the two diets, and the results are presented in Table 5 . No consistent changes in the fractional catabolic rate of 125 I-LDL were noted between the control and fish-oil-rich diets, and on an individual basis, the FCR fell in five patients and increased in two on the fish-oil-rich diet. Mean values for the FCR decreased slightly from 0.40 ± 0 . 1 2 pools/day (SD) on the control diet to 0.36 ± 0.05 pools/day (SD) on the omega-3-enriched diet ( Table  5 ). The synthetic rate of LDL apoprotein B was significantly lower (p < 0.05) on the fish-oil diet (9.5 ± 1.3 mg/kg/day) as compared to the control diet (13.6 ± 3.7 mg/kg/day; mean ± SD); on an individual basis the synthetic rate was lower in six of the seven study subjects. These conclusions are still valid if data from Subject 2 (in whom the synthetic rate of apo LDL decreased from 21.2 mg/kg/day on the control diet to 9.9 mg/kg/day on the fish-oil diet) is excluded, and in this case the mean values of six subjects for the synthetic rates of apo LDL on the control and fish-oil diets are 12.4 + 1.6 mg/kg/day and 9.4 + 1.4 mg/kg/day, respectively, (p < 0.05). Our results indicate that the lower concentrations of LDL seen in subjects on the fish-oil-enriched diet as compared to the control diet are due to a reduction in the rate of synthesis of LDL apoprotein B, rather than to an increased fractional rate of catabolism.
Discussion
Reductions in the plasma concentrations of LDL in human subjects consuming diets rich in long-chain omega-3 fatty acids from fish oils or omega-6 fatty acids from vegetable oils may be due to a reduction in LDL synthesis, an increased fractional rate of catabolism of LDL, or a combination of both. Several previous studies have examined the mechanism(s) by which diets rich in linoleic acid (18:2, omega-6) lower plasma LDL concentrations in both normal and hypercholesterolemic human subjects, 16 " 19 but our study is the first to examine the hypolipidemic mechanisms of omega-3 fatty acids. Turner et al. 16 observed significantly lower rates of synthesis of LDL apoprotein B in both normal and hypercholesterolemic human subjects fed safflower oil (P/S ratio 8.0) as compared to lard (P/S ratio 0.2) at 40% of total calories. Although these changes were paralleled by an increase in the fractional rate of catabolism of LDL on the former diet, this change was statistically significant only in the hypercholesterolemic patients. A lower rate of LDL synthesis with no change in the FCR was reported by Cortese et al. 17 in four hypertriglyceridemic patients fed isocaloric diets (40% fat) enriched in sunflower oil (P/S ratio 3.8) as compared to butter fat (P/S ratio 0.1). In contrast to the decrease in LDL synthesis observed in these studies, two other studies 18 ' 19 have concluded that the hypolipidemic effects of polyunsaturated vegetable oils result primarily from an increased fractional rate of LDL catabolism which were accompanied by smaller (but not significant) decreases in LDL synthesis. The present study indicates that the hypocholesterolemic effects of long-chain omega-3 fatty acids present in fish oils results from a reduction in the rate of LDL apoprotein B synthesis and that such oils do not stimulate the fractional rate of catabolism of LDL. These observations imply that the incorporation of omega-3 fatty acids into cellular or lipoprotein lipids does not enhance the rate of receptor-mediated catabolism of LDL as has been observed with omega-6 fatty acids in vitro. 20 In normal human subjects, virtually all the apoprotein B in LDL is derived from the intravascular catabolism of VLDL; however the proportion of VLDL apoprotein B that is converted to LDL varies widely 17.21-23 T n j s precursor-product relationship implies that in normal humans reductions in the rate of synthesis of LDL can be mediated either by a lower rate of VLDL production or by a reduction in the proportion of VLDL apo B converted to LDL (i.e., an increased rate of direct removal of VLDL remnants). The observed reductions in LDL apo B synthesis by dietary omega-3 fatty acids could, therefore, result from a primary inhibition of VLDL synthesis, an enhanced direct clearance of VLDL remnants, or a combination of both these mechanisms. Evidence to support the former mechanism includes the marked hypotriglyceridemic effects of omega-3 fatty acids when fed to patients with hypertriglyceridemia 1 and the ability of small amounts of these oils to inhibit carbohydrate-induced hypertriglyceridemia in normal subjects. 24 These observations are also consistent with recent studies in which omega-3 fatty acids have been found to inhibit hepatic lipogenesis in animals 25 and in cultured rat hepatocytes.
26
Because of their hypolipidemic and antithrombotic effects, supplemental dietary omega-3 fatty acids may prove to have important clinical applications in the treatment of hyperlipidemia and, potentially, in the prevention of atherosclerosis.
